PCSK9 vaccine
US9481875B2 · kind B2 · utility
0Cited by
6References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 7, 2014 |
| Grant date | Nov 1, 2016 |
| Priority date | — |
| Expiry date | Oct 7, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y304/21061
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the provision of immunogens comprising an antigenic PCSK9 peptide linked to an immunogenic carrier for the prevention, treatment or alleviation of PCSK9-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.